FDA Rules Against New Painkiller
A Food and Drug Administration advisory panel has recommended against approving a new powerful prescription painkiller.
“Mox-duo” combines the opioids morphine and oxycodone in one capsule. Its manufacturer says the drug provides quick relief to patients suffering intense pain from accidents and surgeries.
But addiction specialists warn Moxduo is dangerous because it’s easy to abuse which could lead to overdoses and even death.
The FDA now decides whether to approve or reject the panel’s recommendation.
